Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR-1210

OBJECTIVE: SHR-1210 is a new and promising anti-PD-1 agent for solid tumors. During the phase I study of SHR-1210, we encountered a novel but prevalent immune-related dermatologic toxicity: reactive capillary hemangiomas (RCHs). Thus we tried to summarize the features of RCHs and estimate their rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xuelian, Ma, Lanying, Wang, Xi, Mo, Hongnan, Wu, Dawei, Lan, Bo, Qu, Dong, Zhang, Hongtu, Huang, Jing, Xu, Binghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528453/
https://www.ncbi.nlm.nih.gov/pubmed/31119058
http://dx.doi.org/10.20892/j.issn.2095-3941.2018.0172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528453/
https://www.ncbi.nlm.nih.gov/pubmed/31119058
http://dx.doi.org/10.20892/j.issn.2095-3941.2018.0172

Ejemplares similares